Shanghai Cagenbio Biotech Co., Ltd.

Company Overview

Established in 2013, Shanghai Cagenbio Science Co.,Ltd. is one of high-tech enterprises, and manufactures diverse pharmaceutical clinical immuno rapid tests, IVD raw materials and POCT analyzers, covering cardiac, liver and kidney, diabetes, tumor, infectious, infertility, hormone, neuropsychopathy, hypertension, etc. Currently our R&D team consists of about 30 persons, including 70% of scholarship, 25% of postgraduate, 4 doctor and postdoctors. We have powerful technological development and self-develop capacity. We created a combined laboratory with Shanghai Jiao Tong University and Fudan University together, guaranteeing strong innovation capacity. Additionally, to keep international primacy, we keep good relationship and communication in biological research area with University of Texas and Texas MD Anderson Cancer Center. Our platforms and products have been successfully developed as follows: medical clinical diagnostic products (100 kinds of immunofluorescence POCT products), 400 kinds of immune diagnostic materials, more than 10 kinds of well-know international and rare products, 5 kinds of patent products, 20 kinds of domestic rare products. Platforms and products have achieved technological breakthrough: biological health products, biological cosmetic, and biological consume products. Projects being developed are biological treatment platform, nano treatment, exosome diagnostic treatment, human source antibody target treatment. Our company has declared successfully 12 national patents and 2 innovation funds of Shanghai small and medium enterprise.